{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:52:10Z","timestamp":1790509930178,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Research"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.neures.2011.12.006","type":"journal-article","created":{"date-parts":[[2011,12,17]],"date-time":"2011-12-17T07:17:32Z","timestamp":1324106252000},"page":"236-242","source":"Crossref","is-referenced-by-count":52,"title":["The cannabinoid agonist WIN55212-2 decreases l-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats"],"prefix":"10.1016","volume":"72","author":[{"given":"Alex","family":"Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Macheda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Morgese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigia","family":"Trabace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giuffrida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.neures.2011.12.006_bib0005","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1523\/JNEUROSCI.2916-06.2007","article-title":"Anandamide regulates postnatal development of long-term synaptic plasticity in the rat dorsolateral striatum","volume":"27","author":"Ade","year":"2007","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.neures.2011.12.006_bib0010","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1073\/pnas.0611532104","article-title":"Protein kinase A activates protein phosphatase 2A by phosphorylation of the B56delta subunit","volume":"104","author":"Ahn","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"37","key":"10.1016\/j.neures.2011.12.006_bib0015","doi-asserted-by":"crossref","first-page":"8432","DOI":"10.1523\/JNEUROSCI.1289-05.2005","article-title":"Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32kDa at the protein kinase A site in striatal projection neurons","volume":"25","author":"Andersson","year":"2005","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neures.2011.12.006_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.20296","article-title":"Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia","volume":"57","author":"Aubert","year":"2005","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.neures.2011.12.006_bib0025","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/35086062","article-title":"Pathophysiology of levodopa-induced dyskinesia: potential for new therapies","volume":"2","author":"Bezard","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"issue":"6762","key":"10.1016\/j.neures.2011.12.006_bib0030","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/45251","article-title":"Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons","volume":"402","author":"Bibb","year":"1999","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neures.2011.12.006_bib0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1471-4159.1990.tb08815.x","article-title":"Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain","volume":"55","author":"Bidaut-Russell","year":"1990","journal-title":"J. Neurochem."},{"issue":"Suppl. 3","key":"10.1016\/j.neures.2011.12.006_bib0040","doi-asserted-by":"crossref","first-page":"S259","DOI":"10.1016\/S1353-8020(08)70013-0","article-title":"Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits","volume":"13","author":"Calabresi","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.neures.2011.12.006_bib0045","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1124\/jpet.107.125666","article-title":"Blockade of cannabinoid type 1 receptors augments the antiparkinsonian action of levodopa without affecting dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys","volume":"323","author":"Cao","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"Suppl. 2","key":"10.1016\/j.neures.2011.12.006_bib0050","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1016\/j.parkreldis.2008.04.021","article-title":"Involvement of the serotonin system in l-dopa-induced dyskinesias","volume":"14","author":"Carta","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"issue":"6","key":"10.1016\/j.neures.2011.12.006_bib0055","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1111\/j.1471-4159.2006.03696.x","article-title":"Role of striatal l-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats","volume":"96","author":"Carta","year":"2006","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.neures.2011.12.006_bib0060","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nrn877","article-title":"Animal models of neurological deficits: how relevant is the rat?","volume":"3","author":"Cenci","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.neures.2011.12.006_bib0065","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-4159.2006.04124.x","article-title":"Post- versus presynaptic plasticity in l-DOPA-induced dyskinesia","volume":"99","author":"Cenci","year":"2006","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.neures.2011.12.006_bib0070","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neuron.2007.05.020","article-title":"Endocannabinoid-mediated long-term plasticity requires cAMP\/PKA signaling and RIM1alpha","volume":"54","author":"Chevaleyre","year":"2007","journal-title":"Neuron"},{"issue":"19","key":"10.1016\/j.neures.2011.12.006_bib0075","doi-asserted-by":"crossref","first-page":"11035","DOI":"10.1073\/pnas.1831768100","article-title":"Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons","volume":"100","author":"Cyr","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"Pt 12","key":"10.1016\/j.neures.2011.12.006_bib0080","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1093\/brain\/awh290","article-title":"Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias","volume":"127","author":"de la Fuente-Fernandez","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.neures.2011.12.006_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-211-33328-0_1","article-title":"Levodopa in the treatment of Parkinson's disease","volume":"71","author":"Fahn","year":"2006","journal-title":"J. Neural Transm. Suppl."},{"issue":"12","key":"10.1016\/j.neures.2011.12.006_bib0090","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1371\/journal.pcbi.0020176","article-title":"DARPP-32 is a robust integrator of dopamine and glutamate signals","volume":"2","author":"Fernandez","year":"2006","journal-title":"PLoS Comput. Biol."},{"issue":"6","key":"10.1016\/j.neures.2011.12.006_bib0095","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1046\/j.1460-9568.2003.02896.x","article-title":"Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias","volume":"18","author":"Ferrer","year":"2003","journal-title":"Eur. J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.neures.2011.12.006_bib0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.physbeh.2007.05.028","article-title":"Signaling in the basal ganglia: postsynaptic and presynaptic mechanisms","volume":"92","author":"Fisone","year":"2007","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.neures.2011.12.006_bib0105","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1152\/jn.2001.85.1.468","article-title":"CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum","volume":"85","author":"Gerdeman","year":"2001","journal-title":"J. Neurophysiol."},{"issue":"4","key":"10.1016\/j.neures.2011.12.006_bib0110","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/7268","article-title":"Dopamine activation of endogenous cannabinoid signaling in dorsal striatum","volume":"2","author":"Giuffrida","year":"1999","journal-title":"Nat. Neurosci."},{"issue":"16","key":"10.1016\/j.neures.2011.12.006_bib0115","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1523\/JNEUROSCI.22-16-06900.2002","article-title":"Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission","volume":"22","author":"Gubellini","year":"2002","journal-title":"J. Neurosci."},{"issue":"Pt 14","key":"10.1016\/j.neures.2011.12.006_bib0120","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1113\/jphysiol.2010.190066","article-title":"Regulation of plasticity of glutamate synapses by endocannabinoids and the cyclic-AMP\/protein kinase A pathway in midbrain dopamine neurons","volume":"588","author":"Haj-Dahmane","year":"2010","journal-title":"J. Physiol."},{"issue":"29","key":"10.1016\/j.neures.2011.12.006_bib0125","doi-asserted-by":"crossref","first-page":"10250","DOI":"10.1073\/pnas.0711880105","article-title":"Interneuron activity controls endocannabinoid-mediated presynaptic plasticity through calcineurin","volume":"105","author":"Heifets","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5977","key":"10.1016\/j.neures.2011.12.006_bib0130","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/310503a0","article-title":"DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1","volume":"310","author":"Hemmings","year":"1984","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neures.2011.12.006_bib0135","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0306-4522(01)00509-7","article-title":"Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain","volume":"109","author":"Hermann","year":"2002","journal-title":"Neuroscience"},{"issue":"7128","key":"10.1016\/j.neures.2011.12.006_bib0140","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nature05506","article-title":"Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models","volume":"445","author":"Kreitzer","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neures.2011.12.006_bib0145","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.nbd.2009.12.027","article-title":"Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat","volume":"38","author":"Lebel","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neures.2011.12.006_bib0150","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neures.2011.12.006_bib0155","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/3-540-26573-2_10","article-title":"Distribution of cannabinoid receptors in the central and peripheral nervous system","volume":"168","author":"Mackie","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"issue":"1","key":"10.1016\/j.neures.2011.12.006_bib0160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neuropharm.2007.04.014","article-title":"Role of the cyclic-AMP\/PKA cascade and of P\/Q-type Ca++ channels in endocannabinoid-mediated long-term depression in the nucleus accumbens","volume":"54","author":"Mato","year":"2008","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neures.2011.12.006_bib0165","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.expneurol.2007.07.021","article-title":"Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors","volume":"208","author":"Morgese","year":"2007","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neures.2011.12.006_bib0170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuint.2008.10.007","article-title":"Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2","volume":"54","author":"Morgese","year":"2009","journal-title":"Neurochem. Int."},{"issue":"4","key":"10.1016\/j.neures.2011.12.006_bib0175","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1471-4159.2002.00876.x","article-title":"Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A","volume":"81","author":"Nishi","year":"2002","journal-title":"J. Neurochem."},{"issue":"1 Suppl. 1","key":"10.1016\/j.neures.2011.12.006_bib0180","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1212\/WNL.62.1_suppl_1.S17","article-title":"The origin of motor fluctuations in Parkinson's disease: importance of dopaminergic innervation and basal ganglia circuits","volume":"62","author":"Obeso","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neures.2011.12.006_bib0185","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(97)00355-8","article-title":"Protein kinase A inhibitor attenuates levodopa-induced motor response alterations in the hemi-parkinsonian rat","volume":"228","author":"Oh","year":"1997","journal-title":"Neurosci. Lett."},{"issue":"4 Suppl. 1","key":"10.1016\/j.neures.2011.12.006_bib0190","first-page":"S167","article-title":"Preventing levodopa-induced dyskinesias","volume":"47","author":"Olanow","year":"2000","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.neures.2011.12.006_bib0195","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1523\/JNEUROSCI.4033-07.2008","article-title":"Endocannabinoid signaling mediates cocaine-induced inhibitory synaptic plasticity in midbrain dopamine neurons","volume":"28","author":"Pan","year":"2008","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neures.2011.12.006_bib0200","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.expneurol.2008.03.009","article-title":"The cannabinoid system in Parkinson's disease: multiple targets to motor effects","volume":"211","author":"Papa","year":"2008","journal-title":"Exp. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.neures.2011.12.006_bib0205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0006-8993(94)90796-X","article-title":"Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration","volume":"662","author":"Papa","year":"1994","journal-title":"Brain Res."},{"issue":"30","key":"10.1016\/j.neures.2011.12.006_bib0210","doi-asserted-by":"crossref","first-page":"11393","DOI":"10.1073\/pnas.0603861103","article-title":"The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin","volume":"103","author":"Patwardhan","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neures.2011.12.006_bib0215","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"issue":"5","key":"10.1016\/j.neures.2011.12.006_bib0220","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","article-title":"Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia","volume":"6","author":"Picconi","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neures.2011.12.006_bib0225","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"issue":"9","key":"10.1016\/j.neures.2011.12.006_bib0230","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1017\/S1461145709991003","article-title":"Individual differences in the effects of cannabinoids on motor activity, dopaminergic activity and DARPP-32 phosphorylation in distinct regions of the brain","volume":"13","author":"Polissidis","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"8","key":"10.1016\/j.neures.2011.12.006_bib0235","doi-asserted-by":"crossref","first-page":"e12322","DOI":"10.1371\/journal.pone.0012322","article-title":"Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in l-DOPA-induced dyskinesia","volume":"5","author":"Santini","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.neures.2011.12.006_bib0240","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/j.1742-4658.2008.06296.x","article-title":"Parkinson's disease: levodopa-induced dyskinesia and signal transduction","volume":"275","author":"Santini","year":"2008","journal-title":"FEBS J."},{"issue":"26","key":"10.1016\/j.neures.2011.12.006_bib0245","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1523\/JNEUROSCI.0852-07.2007","article-title":"Critical involvement of cAMP\/DARPP-32 and extracellular signal-regulated protein kinase signaling in l-DOPA-induced dyskinesia","volume":"27","author":"Santini","year":"2007","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neures.2011.12.006_bib0295","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/mds.10312","article-title":"Effect of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high-dose levodopa in the reserpine-treated rat model of Parkinson's disease","volume":"18","author":"Segovia","year":"2003","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.neures.2011.12.006_bib0250","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1152\/physrev.00001.2005","article-title":"PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis","volume":"85","author":"Seino","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neures.2011.12.006_bib0255","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1042\/bj20030484","article-title":"The role of serine\/threonine protein phosphatases in exocytosis","volume":"373","author":"Sim","year":"2003","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.neures.2011.12.006_bib0260","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ana.10814","article-title":"Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy","volume":"55","author":"Tong","year":"2004","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.neures.2011.12.006_bib0265","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1523\/JNEUROSCI.4082-10.2011","article-title":"The distinct role of medium spiny neurons and cholinergic interneurons in the D\/AA receptor interaction in the striatum: implications for Parkinson's disease","volume":"31","author":"Tozzi","year":"2011","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neures.2011.12.006_bib0270","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0306-4522(97)00436-3","article-title":"Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system","volume":"83","author":"Tsou","year":"1998","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.neures.2011.12.006_bib0275","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1096\/fj.04-3010fje","article-title":"A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease","volume":"19","author":"van der Stelt","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.neures.2011.12.006_bib0280","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.brainres.2010.09.086","article-title":"The effects of cannabinoid drugs on abnormal involuntary movements in dyskinetic and non-dyskinetic 6-hydroxydopamine lesioned rats","volume":"1363","author":"Walsh","year":"2010","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.neures.2011.12.006_bib0285","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/35081514","article-title":"Roles of serine\/threonine phosphatases in hippocampal synaptic plasticity","volume":"2","author":"Winder","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.neures.2011.12.006_bib0290","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/nbdi.2002.0499","article-title":"l-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson's disease: relation to motor and cellular parameters of nigrostriatal function","volume":"10","author":"Winkler","year":"2002","journal-title":"Neurobiol. Dis."}],"container-title":["Neuroscience Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010211021456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010211021456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T01:33:50Z","timestamp":1561080830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168010211021456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0168010211021456"],"URL":"https:\/\/doi.org\/10.1016\/j.neures.2011.12.006","relation":{},"ISSN":["0168-0102"],"issn-type":[{"value":"0168-0102","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}